Von Hippel-lindau Disease
📧 Sign up to get email alerts when something new happens for Von Hippel-lindau Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
An ongoing clinical study at Peking University First Hospital to develop a multidimensional prediction model for the natural history of von …
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: MyVHL: Patient Natural History Study
This clinical trial update describes the MyVHL: Patient Natural History Study (NCT03749980), an observational study currently recruiting to …
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: 68Ga-NY104 PET/CT in Von Hippel-Lindau Disease [Phase 2]
Phase 2 clinical trial update on 68Ga-NY104 PET/CT imaging for Von Hippel-Lindau disease.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab [Phase 1, Phase 2]
Phase I/II intravitreal trial evaluating a combination of E10030 (PDGF antagonist) and ranibizumab (VEGF antagonist) for severe ocular Von H…
-
CLINICAL_TRIALS research · 2018-11-14Clinical Trial Update: Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease
A completed clinical trial studying the natural history and management of pancreatic lesions in patients with Von Hippel-Lindau disease, wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome [Phase 1]
A Phase 1 clinical trial update evaluating intravitreal ranibizumab injections to treat retinal tumors in patients with Von Hippel-Lindau di…
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
A clinical trial is screening for endolymphatic sac tumours in patients with Von Hippel-Lindau disease, with recruitment ongoing.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 [Phase 2]
Phase 2 clinical trial update evaluating PTK787/ZK 222584 (vatalanib) for Von Hippel-Lindau-related CNS and retinal hemangioblastomas; study…
-
CLINICAL_TRIALS research · 2015-11-13Clinical Trial Update: Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?
This clinical trial update describes research on assessing residual VHL function in tumors to predict the individual course of von Hippel-Li…
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Phase II Study of Vandetanib in Individuals With Kidney Cancer [Phase 2]
Phase II study of vandetanib in renal cancer and Von Hippel-Lindau syndrome has completed with results posted.
-
CLINICAL_TRIALS research · 2012-10-25Clinical Trial Update: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy [Phase 1, Phase 2]
Phase 1/2 clinical trial update on treatments for exudative and vasogenic chorioretinal diseases including AMD variants and other CNV-relate…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease [Phase 2]
A Phase 2 trial evaluating sunitinib in patients with Von Hippel-Lindau disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease [EARLY_Phase 1]
A Phase 1 trial of bevacizumab (Avastin) for unresectable or recurrent hemangioblastomas in Von Hippel-Lindau disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow [Phase 2]
Phase 2 trial evaluating sunitinib malate in patients with Von Hippel-Lindau disease and VHL-associated lesions; the study was terminated an…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
This document covers the natural history and pathobiology of endolymphatic sac tumors in Von Hippel-Lindau disease and describes a prospecti…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome [Phase 1]
Phase 1 trial update of EYE001 for treating retinal tumors in patients with von Hippel-Lindau disease.